Zydus Lifesciences informs about press release

19 Jul 2024 Evaluate
Zydus Lifesciences has informed that it enclosed press release ‘Zydus receives final approval from the USFDA for its NDA Zituvimet TM XR (sitagliptin and metformin hydrochloride) extended-release tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

908.90 7.60 (0.84%)
31-Dec-2025 10:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.80
Dr. Reddys Lab 1261.80
Cipla 1493.00
Zydus Lifesciences 908.90
Lupin 2081.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×